PEPTIDE CONSTRUCTS COMBINED WITH STATIN DRUGS AND USE THEREOF
This application is directed to compositions comprising of isolated aggregated peptide constructs that are formulated with inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase commonly known as statins as well as methods of treating sepsis, FOXO1 related diseases, and other disorders, for improved efficacy and toxicity profile as compared to naked drug.